ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Delcath Systems Inc

Delcath Systems Inc (DCTH)

7.63
0.21
(2.83%)
Closed June 15 4:00PM
7.6592
0.0292
(0.38%)
After Hours: 7:37PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
7.6592
Bid
7.23
Ask
8.00
Volume
149,300
7.38 Day's Range 7.63
2.25 52 Week Range 8.50
Market Cap
Previous Close
7.42
Open
7.50
Last Trade
67
@
7.57
Last Trade Time
Financial Volume
$ 1,130,066
VWAP
7.5691
Average Volume (3m)
276,241
Shares Outstanding
22,046,101
Dividend Yield
-
PE Ratio
-3.51
Earnings Per Share (EPS)
-2.16
Revenue
2.07M
Net Profit
-47.68M

About Delcath Systems Inc

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy... Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Delcath Systems Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker DCTH. The last closing price for Delcath Systems was $7.42. Over the last year, Delcath Systems shares have traded in a share price range of $ 2.25 to $ 8.50.

Delcath Systems currently has 22,046,101 shares outstanding. The market capitalization of Delcath Systems is $167.55 million. Delcath Systems has a price to earnings ratio (PE ratio) of -3.51.

DCTH Latest News

Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath’s Board of Directors

Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, is pleased to...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.109216.9343511456.557.746.421268627.04069192CS
40.60928.641134751777.058.56.332392937.37010087CS
122.969263.30916844354.698.54.262762416.03781876CS
264.3492131.3957703933.318.53.12592425.06322968CS
520.749210.84225759776.918.52.257689745.1656861CS
156-4.2308-35.58284272511.8914.952.252837185.33952135CS
2603.8892103.1618037143.7725.182.252390026.51839821CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KAVLKaival Brands Innovations Group Inc
$ 5.96
(338.24%)
70.99M
LRHCLa Rosa Holdings Corporation
$ 1.165
(90.61%)
40.6M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
BRFHBarfresh Food Group Inc
$ 3.03
(38.36%)
247.31k
NNENano Nuclear Energy Inc
$ 9.37
(32.53%)
1.77M
NXLNexalin Technologies Inc
$ 0.89
(-35.52%)
3.93M
INABIN8bio Inc
$ 1.095
(-34.82%)
4.92M
QXOQXO Inc
$ 134.10
(-34.71%)
142.29k
GANXGain Therapeutics Inc
$ 1.24
(-34.39%)
3.09M
KYTXKyverna Therapeutics Inc
$ 9.52
(-34.07%)
4.31M
NVDANVIDIA Corporation
$ 131.88
(1.75%)
309.34M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
KITTNauticus Robotics Inc
$ 0.1921
(19.69%)
165.83M
CRKNCrown Electrokinetics Corporation
$ 0.0582
(-21.35%)
136.77M
SQQQProShares UltraPro Short QQQ
$ 8.43
(-1.29%)
112.46M

DCTH Discussion

View Posts
Filterthenoise Filterthenoise 1 month ago
$DCTH strong
👍️0
Monksdream Monksdream 3 months ago
DCTH 10Q due 3/26
👍️0
Filterthenoise Filterthenoise 4 months ago
$DCTH
👍️0
Filterthenoise Filterthenoise 6 months ago
Lets go $DCTH
👍️0
green maschine green maschine 10 months ago
6 now. That was quick.
👍️0
TheFinalCD TheFinalCD 10 months ago
5.80 HI :0)
👍️0
green maschine green maschine 10 months ago
The 5 analysts offering 12-month price forecasts for Delcath Systems Inc have a median target of 18.00, with a high estimate of 22.00 and a low estimate of 13.00. The median estimate represents a +216.62% increase from the last price of 5.69.
👍️0
dande1990 dande1990 10 months ago
H.C. Wainwright Reaffirms Their Buy Rating on Delcath Systems (DCTH)

TipRanks

 Aug. 15, 2023, 09:35 AM

In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Delcath Systems (DCTH – Research Report), with a price target of $18.00. The company’s shares opened today at $5.84.
👍️0
dande1990 dande1990 10 months ago
HC Wainwright & Co. Maintains Delcath Systems (DCTH) Buy Recommendation

Story by George Maybach • 14h

?

Fintel reports that on August 15, 2023, HC Wainwright & Co. maintained coverage of Delcath Systems (NASDAQ:DCTH) with a Buy recommendation.
Analyst Price Forecast Suggests 436.15% Upside
As of August 2, 2023, the average one-year price target for Delcath Systems is 16.73. The forecasts range from a low of 10.10 to a high of $23.10. The average price target represents an increase of 436.15% from its latest reported closing price of 3.12.

👍️0
TheFinalCD TheFinalCD 10 months ago
5.13 LO :/


SO FAR
👍️0
green maschine green maschine 10 months ago
Hope you get that back working soon. I use TD Ameritrade and so far haven't had any problems with their system.
👍️0
dande1990 dande1990 10 months ago
No... On my app and my laptop I have a message saying they are unable to at the moment

$DCTH
👍️0
green maschine green maschine 10 months ago
Wow, bummer. Did they say why?
👍️0
dande1990 dande1990 10 months ago
Fidelity is down. Cant make trades at all.

$DCTH
👍️0
green maschine green maschine 10 months ago
Awesome! I need to get my correct my sleeping habits - kicking myself today.
👍️0
dande1990 dande1990 10 months ago
Ive been able to do 5.01 to 5.77 and 5.55 to 7.25. In again at 6.33.
👍️0
green maschine green maschine 10 months ago
Nice move CD. Still climbing. $$DCTH$$
👍️0
green maschine green maschine 10 months ago
I'm in at 5.43, went back to bed and missed the flip today. Oh well might see 10 by EOW.
👍️0
dande1990 dande1990 10 months ago
This board needs some life!! Lets go $DCTH
👍️0
TheFinalCD TheFinalCD 10 months ago
round ii

filled as low as 6.46 on that DIP

$DCTH
👍️0
TheFinalCD TheFinalCD 10 months ago
$7!!!!!!!!!!!!!!


SOLD SOME 6.95 AFTER 7 COULDNT BREAK HARD
👍️0
TheFinalCD TheFinalCD 10 months ago
6.70 LG!!!!!!
👍️0
SriMaharaj SriMaharaj 10 months ago
Told you guys. Get in now before it's too late.
👍️0
SriMaharaj SriMaharaj 10 months ago
Wait until it cross $6. You will see $10 today or tomorrow.
👍️0
TheFinalCD TheFinalCD 10 months ago
6.50 WAS A NICE POP OFF MY 5.55 ENTRY
👍️0
green maschine green maschine 10 months ago
Yeah there's resistance at that level, but I believe it'll break through today. Too much buying pressure here. FDA approval is huge news.
👍️0
Filterthenoise Filterthenoise 10 months ago
BOOM $DCTH
👍️0
TheFinalCD TheFinalCD 10 months ago
6.24 SO FAR BUT THEY QUICKLY SOLD IT OFF TO 5.34

DCTH
👍️0
Monksdream Monksdream 10 months ago
Early Barchart Top 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
green maschine green maschine 10 months ago
Good morning. I wonder how high this flies today.
👍️0
TheFinalCD TheFinalCD 10 months ago
https://finviz.com/quote.ashx?t=DCTH&p=d

$DCTH 🚨 Approved

Finally after years of try.

Delcath Systems, Inc. Announces FDA Approval of HEPZATO KIT™ for the Treatment of Adult Patients with Unresectable Hepatic-Dominant Metastatic Uveal Melanoma. pic.twitter.com/ZCBQZXbgzE— Ripster📈📉 (@ripster47) August 15, 2023
👍️0
green maschine green maschine 10 months ago
Where is everybody?
👍️0
Carlito78 Carlito78 10 months ago
What ever happened to SamnotSamuel?
👍️0
harvest1 harvest1 10 months ago
Wow stock is down 2 weeks before PDUFA date. Hard to imagine this wont be approved this time with no adcom. Not sure why there arent more buyers. Hopefully there is a pop on approval and they have a quick launch and revenue ramp.
👍️0
Filterthenoise Filterthenoise 1 year ago
Finally! Go $DCTH
👍️0
Jmma Jmma 1 year ago
Finally looks promising for real. Had shares few years ago and got chewed up and spit out . Reverse splits wiped out a lot of investors. Looks like they turned the corner and could become the investment everyone hoped for awhile back. Good luck to those holding.
👍️0
Filterthenoise Filterthenoise 1 year ago
No one loving the start of the run?
👍️0
Filterthenoise Filterthenoise 1 year ago
Next leg time LFG $DCTH!!
👍️0
Filterthenoise Filterthenoise 2 years ago
$DCTH... LFG!
👍️0
Filterthenoise Filterthenoise 2 years ago
Let's GO!

$DCTH
👍️0
Filterthenoise Filterthenoise 2 years ago
Another run at it coming

GLTA
👍️0
harvest1 harvest1 2 years ago
A new corporate presentation was posted to the company's website with alot of updated information.
https://delcath.com/investors/events-presentations/

This company has been left for dead by the market but I think the stock could recover strongly next year after approval if revenues begin to roll in. I would be interested to hear others thoughts on catalysts and stock price targets. I think at least a $100 million market cap should be expected on approval. Longer term at least $250 million market cap when revenues are material. Starting 3 new trials in 2023 will be positive as well. There appears to be little interest or attention for the company now but hopefully that changes after approval. My biggest fear is that they will have to dilute more at these awful rock bottom prices.
👍️0
Filterthenoise Filterthenoise 2 years ago
Here we go...
👍️0
nealhugh nealhugh 2 years ago
just waiting.........................................................................
👍️0
nealhugh nealhugh 2 years ago
yup--- good chat with GA... TY. Neal
👍️0
nealhugh nealhugh 2 years ago
FDA submission Summer/Fall 2022
FDA approval possible within 6 mos of submission

Fund raise? when?

Stock price lousy so wait for the fund raise?

All results on trials and use are good!

TY, Neal
👍️0
nealhugh nealhugh 2 years ago
https://ih.advfn.com/p.php?pid=nmona&article=87441339
👍️0
nealhugh nealhugh 2 years ago
Yeah--- I had Covid so I have been delayed!!! :)
👍️0
nealhugh nealhugh 2 years ago
Yeah--- I had Covid so I have been delayed!!! :)
👍️0
highstreettrader highstreettrader 2 years ago
Better call Toronto!! Lol
👍️0

Your Recent History

Delayed Upgrade Clock